Results for tag: SOFT trial Total Items Found: 8

Andrew Seidman and Meredith Regan on the TEXT and SOFT Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
breast cancer
TEXT trial
SOFT trial
freedom from distant recurrence
adjuvant endorcine therapy
premenopausal
HR-positive
HER2-negative

Created: 6/6/2018 3:39:24 PM

Harold J. Burstein, MD, PhD, on HR+ Early Breast Cancer: Update of the SOFT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
early breast cancer
SOFT trial
tamoxifen
ovarian function suppression
premenopausal
hormone receptor-positive

Created: 12/7/2017 6:27:27 PM

Ann H. Partridge MD MPH on Patient-Reported Outcomes From the SOFT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer sympos
soft trial
breast cancer
ovarian suppression
patient-reported outcomes
quality of life
oncology
cancer
asco post
ann h. partridge

Created: 1/31/2016 9:39:50 AM

Charles E Geyer Jr MD FACP on the SOFT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer sympos
charles e. geyer
breast cancer
soft trial
ovarian suppression
cancer
oncology
asco post

Created: 1/31/2016 9:38:23 AM

Prudence Francis MD and Hope Rugo MD on the SOFT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer sympos
prudence francis
hope rugo
soft trial
tamoxifen
breast cancer
premenopausal
ovarian function suppression
cancer
oncology
asco post

Created: 1/31/2016 9:34:15 AM

Ismail Jatoi, MD, PhD, FACS, and Clifford A. Hudis, MD, FACS, Discuss the SOFT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
SOFT trial
ovarian suppression
tamoxifen
aromatase inhibitors

Created: 1/31/2016 9:30:09 AM

Larry Wickerham MD and Charles E Geyer Jr MD FACP on Results from NSABP B-36 and SOFT Trials

Type of Page:TapVideo
Edit This Item
Tags for this item:
San Antonio Breast Cancer Sympos
NSABP B-36
SOFT trial
FEC 100
AC
trastuzumab
HER2-positive
aromatase inhibitors
ovarian suppression
exemestane
Oncotype DX
estrogen receptor-positive

Created: 1/31/2016 9:28:04 AM

Julie Gralow, MD, and Clifford A. Hudis, MD, on Bisphosphonates as Adjuvant Therapy in Primary Breast Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2015
Julie Gralow
University of Washington
Cliff Hudis
Memorial Sloan Kettering
bone metastases
bisphophonates
ibandronate
TEXT trial
SOFT trial
calcium
vitamin D
pre-menopausal
stroma
ABCSG trial
aromatase inhibitors
RANK lignad inhibitors
SWOGS0307

Created: 1/31/2016 8:58:04 AM
Order By Item Count
Order Alphabetically